EDWARD HURWITZ
CIK 1211840 · last filed 2026-06-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$8.60M
Companies
6
Total Filings
50
Lifetime Open-Market Net
-$2.99M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DYN | Director | 91,081 | $18.19 | $1.66M | $0 | 7 | 2026-06-09 |
| MGNX | Director | 1,752,820 | $3.96 | $6.94M | -$11.19M | 18 | 2026-05-20 |
| APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Director | 0 | $0.39 | $0 | $0 | 12 | 2022-12-01 |
| Tvardi Therapeutics, Inc. (CARA) Delisted | Director | 1,650,117 | $15.96 | $26.34M | $8.69M | 2 | 2014-02-05 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | Director | 732,745 | $18.62 | $13.64M | -$4.49M | 9 | 2013-07-02 |
| Molecular Templates, Inc. (THLD) Delisted | 1,536,625 | — | — | $4.00M | 1 | 2009-10-06 |
Recent Filings · Page 4 of 5
50 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-05-21 | MGNX | Grant (A) | — | $0 | EDGAR |
| 2015-05-13 | MGNX | Other (J) | +18,074 | $0 | EDGAR |
| 2014-12-23 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-11-19 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Other (J) | +1,800 | $0 | EDGAR |
| 2014-02-18 | MGNX | Sell (S) | −308,513 | -$11.26M | EDGAR |
| 2014-02-05 | Tvardi Therapeutics, Inc. (CARA) Delisted | Mixed | +13,400,933 | $8.69M | EDGAR |
| 2014-01-31 | Tvardi Therapeutics, Inc. (CARA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-10-18 | MGNX | Mixed | +2,013,509 | $0 | EDGAR |
| 2013-10-11 | MGNX | Grant (A) | — | $0 | EDGAR |
| 2013-07-02 | Viracta Therapeutics, Inc. (SNSS) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.